International Patent: PROLONGED-RELEASE DOSAGE FORMS OF FERROPORTIN INHIBITORS FOR USE IN TREATING HEREDITARY HAEMOCHROMATOSIS

GENEVA, June 26 -- VIFOR (INTERNATIONAL) AG filed a patent application (EP2025/085692) for “PROLONGED-RELEASE DOSAGE FORMS OF FERROPORTIN INHIBITORS FOR USE IN TREATING HEREDITARY HAEMOCHROMATOSIS”. With publication no. WO/2026/120152, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4439

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....